146 related articles for article (PubMed ID: 33963715)
1. [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].
Wang H; Chen X; Chen Y; Cao Y; Chen Y; Liu G; Huang L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):555-561. PubMed ID: 33963715
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer.
Chen X; Zha Z; Wang Y; Chen Y; Pang M; Huang L; Chen Y
J Ovarian Res; 2022 Jun; 15(1):69. PubMed ID: 35668504
[TBL] [Abstract][Full Text] [Related]
3. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
4. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
6. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
7. A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate.
Qiu X; Guo D; Du J; Bai Y; Wang F
Medicine (Baltimore); 2021 Feb; 100(8):e24898. PubMed ID: 33663122
[TBL] [Abstract][Full Text] [Related]
8. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
10. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
11. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
12. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
14. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
15. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
16. Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database.
Quan LL; Liu JY; Qu LX; La H; Wang HL; Chen XX; Wang N; Wei ZZ
Bioengineered; 2021 Dec; 12(2):9290-9300. PubMed ID: 34806539
[TBL] [Abstract][Full Text] [Related]
17. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
19. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
20. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]